丹麦制药巨头诺和诺德最近发布了2025上半年财报，“减肥神药”司美格鲁肽三款剂型实现1127.56亿丹麦克朗（约167亿美元）的销售额，合计贡献近73%的营收，这被视作司美格鲁肽正式接过K药全球“药王”权杖的关键一刻。

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in ...

Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...